Aptorum Group Limited

(NASDAQ:APM)

Latest On Aptorum Group Limited (APM):

Date/Time Type Description Signal Details
2023-05-01 19:12 ESTNewsAptorum's subsidiary Paths Innovation to merge with Universal Sequencing Technology, shares up 8.3%N/A
2023-04-29 04:58 ESTNewsAptorum Group GAAP EPS of -$2.75 beats by $2.32, revenue of $1.3M misses by $5.95MN/A
2023-03-27 11:34 ESTNewsAptorum Group signs LOI to acquire URF HoldingN/A
2023-02-11 00:00 ESTNewsAptorum Group regains compliance with nasdaq minimum bid priceN/A
2023-01-20 15:14 ESTNewsAptorum Group climbs 3%, announces 1-for-10 reverse stock splitN/A
2022-12-09 14:25 ESTNewsAptorum Group dips on offering of $3M convertible note due 2023N/A
2022-11-21 05:35 ESTNewsAptorum gets Nasdaq minimum bid price deficiency noticeN/A
2022-10-03 08:15 ESTNewsAptorum Group GAAP EPS of -$0.05N/A
2022-04-29 20:26 ESTNewsAptorum Group GAAP EPS of -$0.71, revenue of $1.54MN/A
2022-02-12 11:45 ESTNewsAptorum Group: Advancing Oncology, Autoimmune And Infectious Disease TherapiesN/A
2022-02-11 16:28 ESTNewsAptorum Group: Advancing Oncology, Autoimmune & Infectious Disease TherapiesN/A
2022-01-10 15:39 ESTNewsAptorum Group launches oncology and autoimmune discovery and development platformN/A
2021-09-17 13:25 ESTNewsAptorum shares rise 9% after FDA greenlight for SACT-1 neuroblastoma trialsN/A
2021-09-17 13:25 ESTNewsAptorum Group reports 1H resultsN/A
2021-07-20 19:24 ESTNewsAptorum Group soars 10% on "positive" interim Phase I data on ALS-4 and progress on SACT-1N/A
2021-07-20 19:05 ESTNewsSCOR, GOGL, KLDO and APM among after-hours moversN/A
2021-07-20 18:53 ESTNewsAptorum releases additional positive results for phase 1 antibiotic candidateN/A
2021-05-07 03:38 ESTNewsAptorum inks development agreement with ExeltisN/A
2021-04-22 09:29 ESTNewsAptorum Group partners with Yale University for immunomodulators development; stock +6%N/A
2021-04-20 01:13 ESTNewsAptorum Group EPS beats by $0.80, beats on revenueN/A
2021-01-20 14:10 ESTNewsAptorum shares jump as Canada approves early-stage infection drug trialN/A
2021-01-20 14:10 ESTNewsNFLX, TELL, CLBS, and FUTU among notable pre-market gainersN/A
2020-12-21 22:34 ESTNewsAptorum plans early-stage study in Canada on lead Acticule candidateN/A
2020-12-13 03:12 ESTFinancialsCompany financials have been released.Neutral
2020-11-15 11:12 ESTFinancialsCompany financials have been released.Neutral
2020-11-01 17:03 ESTFinancialsCompany financials have been released.Neutral
2020-10-01 04:39 ESTNewsAptorum Group raises $9M in public offeringN/A
2020-09-29 22:16 ESTNewsAptorum Group rockets 10-fold on launch of infectious disease liquid biopsy unitN/A
2020-09-26 04:15 ESTFinancialsCompany financials have been released.Neutral
2020-09-04 20:07 ESTFinancialsCompany financials have been released.Neutral
2020-09-03 14:08 ESTNewsAptorum Group stumbles 10% post 1H resultsN/A
2020-09-03 14:07 ESTNewsAptorum Group Limited 2020 Q2 - Results - Earnings Call PresentationN/A
2020-09-02 16:07 ESTFinancialsCompany financials have been released.Neutral
2020-09-02 07:10 ESTNewsAptorum +18% on positive SACT-1 data against neuroblastoma and other tumorsN/A
2020-07-31 00:10 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 16:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $23 to $13.Neutral
2020-07-28 12:07 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:15 ESTFinancialsCompany financials have been released.Neutral
2020-07-20 16:08 ESTEarnings EstimateAn EPS average of -$0.84 is estimated for the 2022 year.N/A
2020-07-20 16:08 ESTEarnings EstimateAn EPS average of -$0.27 is estimated for the quarter ending on June 30, 2021.N/A
2020-07-20 16:08 ESTAnalyst RatingThe Analyst Target Price has decreased from $35 to $23.Neutral
2020-06-02 16:16 ESTEarnings EstimateAn EPS average of -$0.72 is estimated for the 2021 year.N/A
2020-05-31 16:33 ESTFinancialsCompany financials have been released.Neutral
2020-05-04 12:08 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 08:09 ESTFinancialsCompany financials have been released.Neutral
2020-05-01 18:13 ESTNewsAptorum Group EPS misses by $0.14, misses on revenueN/A
2020-05-01 04:07 ESTFinancialsCompany financials have been released.Neutral
2020-04-29 20:07 ESTEarnings EstimateAn EPS average of -$0.49 is estimated for the 2020 year.N/A
2020-04-11 01:11 ESTNewsCovid-19 activity roundup - healthcareN/A
2020-04-09 00:07 ESTFinancialsCompany financials have been released.Neutral

About Aptorum Group Limited (APM):

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. Its pipeline through the establishment of drug discovery platforms enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.

APM Quotes by TradingView

See Advanced Chart

General

  • Name Aptorum Group Limited
  • Symbol APM
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 36
  • Last Split Factor3:1
  • Last Split Date2011-05-02
  • Fiscal Year EndDecember
  • IPO Date2018-12-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.aptorumgroup.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 154.44
  • Price/Book (Most Recent Quarter) 5.59
  • Enterprise Value Revenue 176.23
View More

Financials

  • Most Recent Quarter 2020-06-30
  • Current Year EPS Estimate -$0.64
  • Next Year EPS Estimate -$0.84
  • Operating Margin -2936%
  • Return on Assets -48%
  • Return on Equity -84%
  • Revenue 622647
  • Earnings Per Share -$0.65
  • Revenue Per Share $0.02
  • Gross Profit -259379
  • Quarterly Earnings Growth 36.5%
View More

Highlights

  • Market Capitalization 108.5 million
  • EBITDA -12622395
  • Analyst Target Price $13
  • Book Value Per Share $0.65
View More

Share Statistics

  • Shares Outstanding 11.57 million
  • Shares Float 7.43 million
  • % Held by Insiders 2643%
  • % Held by Institutions 0.77%
  • Shares Short 334111
  • Shares Short Prior Month 253830
  • Short Ratio 0.64
  • Short % of Float 4%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta -0.16
  • 52 Week High $4.98
  • 52 Week Low $1.16
  • 50 Day Moving Average 3.34
  • 200 Day Moving Average 2.65
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Aptorum Group Limited (APM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aptorum Group Limited (APM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-03-312020-06-30$N/A-$0.10$0.00
2019-12-312020-03-31$N/A-$0.10$0.00
2019-09-302019-12-31$N/A-$0.17$0.00
2019-06-302019-09-30$119896-$0.17$0.00
2019-03-312019-06-30$119896-$0.16$0.00
2018-12-312019-03-31$178394-$0.16$0.00
2018-09-302018-12-31$178394-$0.17$0.00
2018-06-302018-09-30$13331-$0.17$0.00
2018-03-312018-06-30$13331-$0.10$0.00
2017-12-312018-03-31$N/A-$0.10$0.00
2017-09-302017-12-31$N/A-$0.03$0.00
2017-06-302017-09-30$N/A-$0.03$0.00
2017-03-312017-06-30$N/A-$0.02$0.00
2016-12-312017-03-31-$0.02$0.00

Aptorum Group Limited (APM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019
Research Development N/A N/A N/A N/A 1.36 million
Income Before Tax N/A N/A N/A N/A -4.82 million
Selling General Administrative N/A N/A N/A N/A 2.62 million
Gross Profit N/A N/A N/A N/A -65713
Ebit N/A N/A N/A N/A -4.1 million
Operating Income N/A N/A N/A N/A -4.1 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A 119896
Cost of Revenue N/A N/A N/A N/A 185609
Total Other Income Expense Net N/A N/A N/A N/A -716113
Net Income From Continuing Operations N/A N/A N/A N/A -4.82 million
Net Income Applicable to Common Shares -3.1 million -3.1 million -4.8 million -4.8 million -4.54 million
Cash Flow:
Date Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities -14691 -14691 N/A N/A N/A
Total Cash Flow from Investing Activities 449321 449321 N/A N/A N/A
Net Borrowings -2.03 million -2.03 million N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A N/A N/A N/A
Change to Operating Activities -202142 -202142 N/A N/A N/A
Change in Cash N/A N/A N/A N/A N/A
Total Cash from Operating Activities -3.51 million -3.51 million N/A N/A N/A
Depreciation N/A N/A N/A N/A N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities -107834 -107834 N/A N/A N/A
Change to Net Income -544531 -544531 N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019
Total Liabailities N/A N/A N/A N/A 718082
Total Stockholder Equity N/A N/A N/A N/A 24.94 million
Other Current Liabilities N/A N/A N/A N/A 3512
Total Assets N/A N/A N/A N/A 24.74 million
Common Stock 30.39 million 30.39 million 29.04 million 29.04 million 29.04 million
Other Current Assets N/A N/A N/A N/A 543398
Retained Earnings -43.76 million -43.76 million -37.56 million -37.56 million -27.96 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets 365795 365795 404439 404439 2.76 million
Cash N/A N/A N/A N/A 4.47 million
Total Current Liabilities N/A N/A N/A N/A 597141
Other Stockholder Equity 25618 25618 -5552 -5552 7345
Property, Plant & Equipment 6.85 million 6.85 million 7.09 million 7.09 million 5.78 million
Total Current Assets N/A N/A N/A N/A 7.74 million
Long Term Investments N/A N/A N/A N/A 7.11 million
Net Tangible Assets 18.62 million 18.62 million 15.05 million 15.05 million 23.59 million
Short Term Investments N/A N/A N/A N/A 1.67 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A 33911
Accounts Payable N/A N/A N/A N/A 548433

Aptorum Group Limited (APM) Chart:

Aptorum Group Limited (APM) News:

Below you will find a list of latest news for Aptorum Group Limited (APM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aptorum Group Limited (APM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest APM Trades:

Date Shares Price
Jun 13, 2022 6:01 PM EST100$1.12

Aptorum Group Limited (APM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020016025/0001213900-20-016025-index.htm
2018-09-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1734005/000000000018029677/0000000000-18-029677-index.htm
2018-10-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1734005/000000000018031953/0000000000-18-031953-index.htm
2018-11-26UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1734005/000000000018036236/0000000000-18-036236-index.htm
2018-12-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1734005/000000000018037813/0000000000-18-037813-index.htm
2019-07-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1734005/000000000019011791/0000000000-19-011791-index.htm
2019-09-03UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1734005/000000000019013066/0000000000-19-013066-index.htm
2020-01-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1734005/000000000020000314/0000000000-20-000314-index.htm
2020-09-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1734005/000000000020008899/0000000000-20-008899-index.htm
2020-09-25UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1734005/000000000020009070/0000000000-20-009070-index.htm
2020-09-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1734005/000000000020009097/0000000000-20-009097-index.htm
2018-03-28SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1734005/000121390018003566/0001213900-18-003566-index.htm
2018-05-25DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1734005/000121390018006874/0001213900-18-006874-index.htm
2018-07-13DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1734005/000121390018009168/0001213900-18-009168-index.htm
2018-09-05F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390018012108/0001213900-18-012108-index.htm
2018-09-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390018012110/0001213900-18-012110-index.htm
2018-10-05F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390018013586/0001213900-18-013586-index.htm
2018-10-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390018013588/0001213900-18-013588-index.htm
2018-10-10FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1734005/000121390018013756/0001213900-18-013756-index.htm
2018-11-15F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390018015857/0001213900-18-015857-index.htm
2018-11-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390018015877/0001213900-18-015877-index.htm
2018-11-28F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390018016613/0001213900-18-016613-index.htm
2018-11-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390018016614/0001213900-18-016614-index.htm
2018-11-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390018016749/0001213900-18-016749-index.htm
2018-11-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390018016758/0001213900-18-016758-index.htm
2018-12-04424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1734005/000121390018016881/0001213900-18-016881-index.htm
2018-12-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390018017243/0001213900-18-017243-index.htm
2018-12-148-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1734005/000121390018017387/0001213900-18-017387-index.htm
2018-12-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390018017489/0001213900-18-017489-index.htm
2019-01-03SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1734005/000121390019000155/0001213900-19-000155-index.htm
2019-01-03SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1734005/000121390019000157/0001213900-19-000157-index.htm
2019-03-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019003523/0001213900-19-003523-index.htm
2019-04-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019005349/0001213900-19-005349-index.htm
2019-04-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019006327/0001213900-19-006327-index.htm
2019-04-1520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1734005/000121390019006328/0001213900-19-006328-index.htm
2019-04-18POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1734005/000121390019006662/0001213900-19-006662-index.htm
2019-04-2220-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1734005/000121390019006842/0001213900-19-006842-index.htm
2019-04-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019007008/0001213900-19-007008-index.htm
2019-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1734005/000121390019008015/0001213900-19-008015-index.htm
2019-05-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1734005/000121390019008016/0001213900-19-008016-index.htm
2019-05-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019009370/0001213900-19-009370-index.htm
2019-05-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019009868/0001213900-19-009868-index.htm
2019-07-02F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390019011933/0001213900-19-011933-index.htm
2019-07-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019012190/0001213900-19-012190-index.htm
2019-07-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1734005/000121390019012430/0001213900-19-012430-index.htm
2019-07-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1734005/000121390019012487/0001213900-19-012487-index.htm
2019-08-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019015761/0001213900-19-015761-index.htm
2019-08-16F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390019016120/0001213900-19-016120-index.htm
2019-08-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390019016122/0001213900-19-016122-index.htm
2019-09-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019017442/0001213900-19-017442-index.htm
2019-09-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019018956/0001213900-19-018956-index.htm
2019-09-27F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390019019227/0001213900-19-019227-index.htm
2019-09-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390019019229/0001213900-19-019229-index.htm
2019-10-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390019020423/0001213900-19-020423-index.htm
2019-10-16F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390019020427/0001213900-19-020427-index.htm
2019-10-16S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1734005/000121390019020433/0001213900-19-020433-index.htm
2019-10-21F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390019020694/0001213900-19-020694-index.htm
2019-10-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390019020697/0001213900-19-020697-index.htm
2019-10-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390019020873/0001213900-19-020873-index.htm
2019-10-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019021074/0001213900-19-021074-index.htm
2019-10-31424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1734005/000121390019021592/0001213900-19-021592-index.htm
2019-11-12POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1734005/000121390019022916/0001213900-19-022916-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390019023630/0001213900-19-023630-index.htm
2019-11-26424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1734005/000121390019024691/0001213900-19-024691-index.htm
2019-12-18F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390019026410/0001213900-19-026410-index.htm
2019-12-26RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1734005/000121390019026955/0001213900-19-026955-index.htm
2020-01-06F-3Registration statement by foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390020000256/0001213900-20-000256-index.htm
2020-01-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020000815/0001213900-20-000815-index.htm
2020-01-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390020000960/0001213900-20-000960-index.htm
2020-02-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020003035/0001213900-20-003035-index.htm
2020-02-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020004538/0001213900-20-004538-index.htm
2020-02-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020004797/0001213900-20-004797-index.htm
2020-02-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1734005/000121390020004950/0001213900-20-004950-index.htm
2020-03-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1734005/000121390020005827/0001213900-20-005827-index.htm
2020-03-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020007824/0001213900-20-007824-index.htm
2020-04-2920-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1734005/000121390020010347/0001213900-20-010347-index.htm
2020-04-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020010348/0001213900-20-010348-index.htm
2020-05-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020011956/0001213900-20-011956-index.htm
2020-06-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020016025/0001213900-20-016025-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020017705/0001213900-20-017705-index.htm
2020-07-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020018438/0001213900-20-018438-index.htm
2020-08-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020022976/0001213900-20-022976-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020023942/0001213900-20-023942-index.htm
2020-09-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020024657/0001213900-20-024657-index.htm
2020-09-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020024906/0001213900-20-024906-index.htm
2020-09-11F-1Registration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390020026236/0001213900-20-026236-index.htm
2020-09-24F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390020028138/0001213900-20-028138-index.htm
2020-09-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390020028140/0001213900-20-028140-index.htm
2020-09-25F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390020028499/0001213900-20-028499-index.htm
2020-09-25CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390020028504/0001213900-20-028504-index.htm
2020-09-28F-1/ARegistration statement for certain foreign private issuershttps://www.sec.gov/Archives/edgar/data/1734005/000121390020028684/0001213900-20-028684-index.htm
2020-09-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390020028751/0001213900-20-028751-index.htm
2020-09-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390020028765/0001213900-20-028765-index.htm
2020-09-29CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1734005/000121390020028789/0001213900-20-028789-index.htm
2020-09-29F-1MEFRegistration statement to add securities to prior Form F-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1734005/000121390020029059/0001213900-20-029059-index.htm
2020-10-01424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1734005/000121390020029638/0001213900-20-029638-index.htm
2020-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020029907/0001213900-20-029907-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020031647/0001213900-20-031647-index.htm
2020-10-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1734005/000121390020032206/0001213900-20-032206-index.htm
2018-12-17CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1734005/000135445718000526/0001354457-18-000526-index.htm
2018-12-03EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1734005/999999999518003027/9999999995-18-003027-index.htm
2019-04-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1734005/999999999519000765/9999999995-19-000765-index.htm
2019-10-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1734005/999999999519002375/9999999995-19-002375-index.htm
2019-11-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1734005/999999999519002605/9999999995-19-002605-index.htm
2020-01-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1734005/999999999520000095/9999999995-20-000095-index.htm
2020-09-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1734005/999999999520002612/9999999995-20-002612-index.htm
2018-12-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1734005/999999999718009210/9999999997-18-009210-index.htm